Start a Full-Service Oncology Contract Research Organization

1. 1

   Build oncology and regulatory expertise

   A CRO's product is expertise: running trials to good-clinical-practice (GCP) standards and FDA and international regulatory requirements. Oncology trials are especially complex given endpoints, patient populations, and the number of competing investigational compounds. The founding team must carry deep clinical-trial and regulatory credentials, because sponsors buy competence and track record.

2. 2

   Stand up quality systems and SOPs

   Standard operating procedures, quality management, data integrity, and pharmacovigilance systems are the backbone that lets a CRO be trusted with a sponsor's program and inspected by regulators. This infrastructure is expensive and non-negotiable. Auditability is a core part of the offering.

3. 3

   Develop site and patient-recruitment capability

   Full-service CROs manage or partner with clinical trial sites and drive patient recruitment, which in oncology is a persistent bottleneck because only a small share of adult patients enroll in trials. Site relationships and recruitment capability differentiate CROs. Slow enrollment is the risk sponsors most want solved.

4. 4

   Win sponsor contracts

   Customers are pharmaceutical and biotech companies, and winning work requires demonstrating therapeutic expertise, quality, speed, and price competitiveness against established CROs. Business development into pharma is a long-cycle enterprise sale. A first marquee client and clean execution build the reputation the next contracts depend on.

5. 5

   Deliver data management and biostatistics

   Trial data capture, management, biostatistics, and regulatory submission support are core deliverables. These require specialized staff and validated systems. Data quality and on-time, submission-ready deliverables are what sponsors ultimately pay for.

6. 6

   Scale people and projects carefully

   A CRO is a people-heavy business where margin comes from utilization and repeatable execution across many trials. Growth means hiring and retaining scarce clinical-research talent while maintaining quality. The functional-service-provider model is a related, narrower way to enter the same market and has its own card.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.